Powered by

9 Meters Biopharma, Inc. to Present Data on Therapeutic Candidate in Short Bowel Syndrome at the American College of Gastroenterology (ACG) 2021 Annual Scientific Meeting

Oct 19, 2021 - Morningstar.com

RALEIGH, NC / ACCESSWIRE / October 19, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases by studying unique GI biology, announced today that the company will deliver a poster presentation highlighting vurolenatide, 9 Meters' therapeutic candidate in short bowel syndrome, and will host a booth exhibit at the in-person component of the American College of Gastroenterology (ACG) 2021 Annual Sci...